Multimillion investment in Danish innovation

January 21, 2016
To boost innovation output, 94 innovative Danish activities receive a €122 million ($132 million) investment. The investment includes activities within medico equipment and pharmaceuticals.

Aiming to improve competitiveness, give innovative Danish companies, organizations and activities better conditions for research, and boost development of new equipment and new methods, the Danish Agency for Science, Technology and Innovation invests €122 million ($132 million) in 94 different innovative activities within medico, pharmaceuticals, and technology. The activities are all part of GTS – Advanced Technology Group, a network of independent Danish research and technology organizations that consults, assists, and co-operates with Danish companies on technological and market-related innovation.

Several activities within life science receive grants and the category, health and food, overall receives 14.1 pct. of the total grant. Among the activities are research projects within immune modulation and stem cell therapy, and optimal utilization of biomarkers in diagnostics, and pharmaceuticals development. All activities must be completed between 2016 and 2018.

Read more about GTS here